| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/MCP.R600006-MCP200 |
| P698 | PubMed publication ID | 16735302 |
| P2093 | author name string | Randall W Nelson | |
| Dobrin Nedelkov | |||
| Eric E Niederkofler | |||
| Kemmons A Tubbs | |||
| Urban A Kiernan | |||
| P2860 | cites work | Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay | Q24794242 |
| A data review and re-assessment of ovarian cancer serum proteomic profiling | Q24806513 | ||
| Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay | Q28115782 | ||
| Population proteomics: addressing protein diversity in humans | Q36184782 | ||
| Probe-immobilized affinity chromatography/mass spectrometry | Q36799404 | ||
| Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics | Q40493491 | ||
| Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? | Q40572496 | ||
| Comparative Urine Protein Phenotyping Using Mass Spectrometric Immunoassay | Q44418259 | ||
| Differences among techniques for high-abundant protein depletion | Q46625303 | ||
| Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems | Q48009299 | ||
| Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. | Q50483624 | ||
| Population proteomics: an emerging discipline to study metapopulation ecology. | Q51190139 | ||
| Clinical proteomics and biomarker discovery. | Q51994218 | ||
| Quantitative mass spectrometric immunoassay of insulin like growth factor 1. | Q52559968 | ||
| Lessons from controversy: ovarian cancer screening and serum proteomics. | Q52973479 | ||
| Serum proteomics profiling—a young technology begins to mature | Q57556800 | ||
| Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer | Q57556802 | ||
| Proteomic patterns to identify ovarian cancer: 3 years on | Q57942263 | ||
| Tabulation of human transthyretin (TTR) variants, 2003 | Q58011075 | ||
| An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum | Q58183437 | ||
| Current developments in SELDI affinity technology | Q28185524 | ||
| A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity | Q28208345 | ||
| Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay | Q30650225 | ||
| Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer | Q30728271 | ||
| Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations | Q30751781 | ||
| High-throughput protein characterization using mass spectrometric immunoassay | Q30800926 | ||
| Use of proteomic patterns in serum to identify ovarian cancer | Q30819686 | ||
| Clinical proteomics for cancer biomarker discovery and therapeutic targeting | Q30893390 | ||
| Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry | Q31044251 | ||
| Proteomic characterization of novel serum amyloid P component variants from human plasma and urine | Q31070258 | ||
| Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml | Q31112683 | ||
| Detection of novel truncated forms of human serum amyloid A protein in human plasma | Q31133257 | ||
| Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility | Q31136536 | ||
| Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population | Q31137860 | ||
| Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions | Q31146589 | ||
| Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. | Q31913738 | ||
| Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins | Q33185913 | ||
| Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry | Q33199436 | ||
| High-throughput comprehensive analysis of human plasma proteins: a step toward population proteomics | Q33199444 | ||
| Clinical proteomics: revolutionizing disease detection and patient tailoring therapy | Q33202393 | ||
| Mass spectrometric immunoassay | Q33202760 | ||
| Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome | Q33209073 | ||
| Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identificati | Q33220605 | ||
| Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry | Q33225139 | ||
| Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 | ||
| Diagnosis of congenital disorders of glycosylation type-I using protein chip technology | Q33237243 | ||
| Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond | Q33702396 | ||
| Investigating diversity in human plasma proteins | Q33905685 | ||
| The International HapMap Project Web site | Q34206586 | ||
| Clinical proteomics: translating benchside promise into bedside reality | Q34810370 | ||
| Proteomic applications for the early detection of cancer | Q35097366 | ||
| Functional protein microarrays: ripe for discovery | Q35703120 | ||
| SPR for molecular interaction analysis: a review of emerging application areas | Q35770270 | ||
| Progress in protein and antibody microarray technology | Q36088884 | ||
| P433 | issue | 10 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1811-1818 | |
| P577 | publication date | 2006-05-30 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Population proteomics: the concept, attributes, and potential for cancer biomarker research | |
| P478 | volume | 5 |
| Q37040674 | "Proteotyping": population proteomics of human leukocytes using top down mass spectrometry |
| Q34973952 | Analysis of human blood plasma proteome from ten healthy volunteers from Indian population |
| Q38068929 | Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project |
| Q59214612 | Contribution of oncoproteomics to cancer biomarker discovery |
| Q37414479 | Delineating Anopheles gambiae coactivator associated arginine methyltransferase 1 automethylation using top-down high resolution tandem mass spectrometry |
| Q51803210 | Demonstration of sandwich and competitive modulated supraparticle fluoroimmunoassay applied to cardiac protein biomarker myoglobin. |
| Q33288265 | Detection of venous thromboembolism by proteomic serum biomarkers |
| Q43906599 | Different expression of S100A8 in malignant and benign gallbladder diseases |
| Q48158874 | Exploring the expression bar code of SAA variants for gastric cancer detection |
| Q33798196 | Fast proteomic protocol for biomarker fingerprinting in cancerous cells. |
| Q37452925 | Glycosylation status of vitamin D binding protein in cancer patients |
| Q37197072 | High-throughput liquid-liquid fractionation of multiple protein post-translational modifications |
| Q38649742 | Human proteoforms as new targets for clinical mass spectrometry protein tests |
| Q35925687 | In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated. |
| Q33457379 | Liquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation |
| Q37566426 | Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms |
| Q37004146 | Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies. |
| Q26995497 | Mass spectrometry for translational proteomics: progress and clinical implications |
| Q36689104 | Mass spectrometry-based immunoassays for the next phase of clinical applications |
| Q35776559 | Molecularly imprinted polymers coupled to matrix assisted laser desorption ionization mass spectrometry for femtomoles detection of cardiac troponin I peptides. |
| Q55368257 | Predicting high-risk endometrioid carcinomas using proteins. |
| Q38179449 | Profiling proteoforms: promising follow-up of proteomics for biomarker discovery. |
| Q47261659 | Protein biomarkers for subtyping breast cancer and implications for future research. |
| Q90024212 | Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity |
| Q33450135 | Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q36841893 | Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches |
| Q38018848 | Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies |
| Q33289397 | Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigens |
| Q28397855 | Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides |
| Q36088189 | Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers |
| Q24628711 | The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions |
| Q27002139 | Top-down proteomics in health and disease: challenges and opportunities |
Search more.